MedTech World

21/04/2026

Capital is influencing the direction of MedTech and understanding where it is moving matters more than ever.

At MedTech World North America, happening on 11–13 May 2026 in West Palm Beach:

Fireside Chat: Follow the Money: MedTech Equities, Trends & Capital Market Forces

This conversation takes a capital markets lens to the sector, exploring investment trends, evolving business models, and the key forces guiding decisions across global MedTech markets.

Insights from:

Moderator
Eileen Ke, Partner, Edge Medical Ventures

Speakers
David Roman, Managing Director, Co-Head of Healthcare Global Investment Research, Goldman Sachs
Joseph Shonkwiler, MD, MBA, Healthcare & Life Science Lead, Venture Capital BD, Google
Jonathan Norris, Managing Director, HSBC

If you are building, investing, or tracking the MedTech market, this is a conversation worth following.

Secure your pass now: https://eu1.hubs.ly/H0tJcn40

21/04/2026

We are honoured to welcome Boris Reznik, PhD, Chairman & CEO of Immorta Bio, to the stage at MedTech World North America.

Boris leads Immorta Bio in advancing senolytic and regenerative therapies, focusing on next-generation approaches to age-related conditions and cellular health. A seasoned entrepreneur, he has built and led multiple high-growth companies, including Inc. 500 firms, and has been involved in IPOs, M&As, and numerous NDA and BLA programs.

His perspective will be valuable for those exploring the future of regenerative medicine, biotech innovation, and scaling breakthrough therapies.

MedTech World North America | West Palm Beach, Florida
11–13 May 2026
Secure your tickets here: https://eu1.hubs.ly/H0tHZYp0

Investor Pass applications are open: https://eu1.hubs.ly/H0tJ3yG0

21/04/2026

€1.2M to tackle one of healthcare’s biggest blind spots: undiagnosed genetic disorders at birth.

gMendel has raised a seed round led by Metavallon VC to scale its AI-powered genetic screening platform across emerging markets.

“This investment marks a pivotal milestone for gMendel® By combining genomics and AI, we have the opportunity to fundamentally change how healthcare systems detect and manage genetic disorders, ultimately saving lives while significantly reducing long-term costs,” said Dr. Chris Kyriakidis, CEO and co-founder of gMendel®

George Karantonis, Partner at Metavallon VC, added: “Having followed the team closely, we have been consistently impressed not only by the strength of the technology, but by their commitment to translating innovation into tangible societal impact.”

With up to 98% sensitivity and 100% specificity reported in clinical studies, the platform is designed to enable faster diagnosis, reduce misdiagnosis, and improve outcomes—especially in regions where screening infrastructure is limited.

Because early detection isn’t just a clinical advantage—it’s a life-saving one.

Read the full article for all details 👇
https://med-tech.world/news/metavallon-vc-backs-gmendel-1-2m-seed-round/

Next Stop: MedTech World North America
11–13 May 2026 | West Palm Beach, Florida
Secure your pass: https://tickets.med-tech.world/medtechworld-usa-2026

gMendel® raises €1.2M in a seed round led by Metavallon VC to expand its AI-powered genetic screening platform across Latin America, the Middle East, and Africa.

21/04/2026

Most treatments focus on managing type 2 diabetes. The real breakthrough lies in achieving long-term remission.

That’s the approach Paltech is bringing to the table.

As a biotech company, Paltech is developing an implantable solution designed to address type 2 diabetes and obesity at their core, aiming to deliver sustained metabolic improvement rather than temporary control.

By rethinking how these chronic conditions are treated, they are contributing to a shift toward more durable, patient-centric outcomes in metabolic health.

We’re pleased to welcome Paltech as a Presenting Company at MedTech World North America 2026.

📍 West Palm Beach, Florida
📅 11–13 May 2026
Secure your pass: https://eu1.hubs.ly/H0tHxGM0

Join us as innovators, investors, and industry leaders come together to explore the next wave of healthcare innovation.

20/04/2026

We are honoured to welcome Cale Garverick, Managing Director at TD Cowen, to the stage at MedTech World North America.

Cale is part of TD Cowen’s Healthcare Coverage Group, bringing over a decade of experience across healthcare investing and advisory. He has completed 150+ transactions totaling $32B and began his career in healthcare investing at OrbiMed and Wedbush PacGrow.

His perspective will be valuable for leaders navigating capital markets, M&A, and the investment landscape shaping innovation in areas such as robotic surgery and AI-driven technologies.

MedTech World North America | West Palm Beach, Florida
11–13 May 2026
Secure your Pass here: https://eu1.hubs.ly/H0tF-Fz0

Investor Pass applications are open: https://eu1.hubs.ly/H0tG1vR0

20/04/2026

In cardiovascular MedTech, Joe Sasson isn't just backing companies, he's building the ecosystem around them.

CCO & EVP at MedAxiom, An ACC Company Ventures and Co-Founder of the HeartX Cardiovascular Accelerator, one of the investors at MedTech World North America 2026.

From AI-powered cardiac diagnostics to remote therapeutic monitoring, his portfolio is a masterclass in where cardiovascular innovation is headed.

Swipe to see the companies backed by MedAxiom Ventures →
Acorai | Cardio Ai | Mediwhale | SafeBeat Rx | Happitech | MindMics | Nanowear | SmartCardia | Caristo Diagnostics and many more

If you're building in CardioTech, Digital Health, or AI-driven MedTech and looking for an investor who doesn't just write cheques, but opens doors to health systems, clinical validation, and real commercialization — this is the room to be in.

📅 11–13 May 2026 | West Palm Beach, Florida
🎟️ Secure your pass: https://eu1.hubs.ly/H0tFTcn0

20/04/2026

If you think MedTech fails because of regulation — you’re looking in the wrong place.

In this episode, Andra Havkic, COO, EvoMed Consulting, shares what actually happens when a “perfect” solution meets the chaos of a real ICU.

Alarms going off. Seconds to react. No room for extra clicks.
That’s where most products fall apart.

Her take is simple — and uncomfortable:
It’s not the hospital. It’s not the clinician.
It’s products built without truly understanding the environment they’re meant for.

Inside the conversation:
• Why “great on paper” often fails in practice
• The real reason clinicians push back
• Why workflow > features, every single time
• What makes a solution actually usable under pressure

If you’re building in MedTech, this isn’t theory — it’s reality.

🎧 Listen on Spotify: https://eu1.hubs.ly/H0tFJwR0

🎥 Watch on YouTube: https://eu1.hubs.ly/H0tFGJX0

20/04/2026

Methinks AI has secured €2.19M in funding for its project Neuro-rescue, aimed at advancing AI-powered neurological diagnosis in emergency departments.

“We know that there are many people living with undiagnosed intracranial aneurysms and other treatable neurological conditions,” said Víctor Salvia Punsoda, VP of R&D at Methinks AI. “The opportunity lies in the fact that non-contrast CT scans are already performed in virtually every hospital.”

The Neuro-rescue project combines AI analysis of routine CT scans with telemedicine support to help clinicians detect critical neurological conditions earlier, even in non-specialised settings.

The initiative aims to improve detection of aneurysms, haemorrhages, and vessel occlusions, while expanding access to expert neurological input across hospitals.

Read the full article for all details 👇
https://eu1.hubs.ly/H0tFcc50

Next Stop: MedTech World North America
11–13 May 2026 | West Palm Beach, Florida
Secure your pass: https://eu1.hubs.ly/H0tFb3L0

17/04/2026

Where capital meets conviction. 💼✨

On 11 May, MedTech World North America opens an exclusive room for a select group of healthcare investors.

The Investor-Only Forum in West Palm Beach is strictly curated, bringing together VCs, angels, family offices, and strategic investors for high-value, peer-to-peer dialogue.

No noise. No spectators. Just serious capital and meaningful connections.

🔒By application only
📍Canopy by Hilton, West Palm Beach
🎟 Conference pass required

Proudly sponsored by Greenberg Traurig

Apply now. The right room changes everything.
https://eu1.hubs.ly/H0tCMsf0?

17/04/2026

We are honoured to welcome Manish Chand, Robotic Surgeon and Technology Researcher at University College London, to the stage at MedTech World North America.

A robotic colorectal surgeon and Professor of Surgery, Manish is a globally recognised trainer and key opinion leader in surgical innovation. His work focuses on the integration of AI, AR, and advanced technologies into clinical practice, while also advising MedTech companies on innovation development and commercialisation.

His perspective will be valuable for those exploring the future of surgery, digital innovation, and technology-driven care.

✈️MedTech World North America | West Palm Beach, Florida
📅11–13 May 2026
🎟️Secure your tickets here: https://eu1.hubs.ly/H0tCLDC0

🔗Investor Pass applications are open: https://eu1.hubs.ly/H0tCN0n0

17/04/2026

Before investing in startups, he was involved in building them.

Meet Shai Policker, Managing Partner at Edge Medical Ventures, and one of the investors at MedTech World North America 2026.

A medical device veteran with over 25 years of experience in development, clinical validation, and commercialization. Former CEO of MEDX Xelerator LP, he built a $150M portfolio and co-founded Edge Medical Ventures in 2024.

Swipe to explore companies backed by Edge Medical Ventures →
Exero Medical | Synchrony Medical | PatenSee | Append Medical | LifeCord | Urologic

📅 11–13 May 2026 | West Palm Beach, Florida
🎟️ Secure your pass: https://eu1.hubs.ly/H0tCsTY0

17/04/2026

i-GENTIC AI is rethinking how life sciences companies approach regulatory compliance, introducing an AI-driven platform designed to manage complexity across the full product lifecycle.

“Organisations should not have to choose between speed and safety. With GENIE, they can have both,” said Zahra Timsah PhD, MBA, MSc, Co-founder and CEO, i-GENTIC AI

At the core is the GENIE platform, which acts as a continuous layer of regulatory intelligence, tracking consistency across submissions, identifying risks before regulators do, and adapting to evolving requirements in real time.

From 510(k) and De Novo to PMA, NDA, and BLA pathways, the platform is built to support both early-stage innovators and large-scale enterprises navigating complex regulatory environments.

With reported improvements in first-time submission success rates and faster approval timelines, the shift toward AI-driven compliance is becoming a competitive advantage.

What role will AI play in redefining regulatory strategy across MedTech and biotech?
Read the full article for all details 👇
https://med-tech.world/news/the-regulatory-edge-i-gentic-ai-life-sciences-compliance/

Next Stop: MedTech World North America 2026
11-13 May 2026 | West Palm Beach
Secure your pass: https://tickets.med-tech.world/medtechworld-usa-2026

Discover how i-GENTIC AI’s GENIE platform is helping life sciences companies strengthen compliance, improve submission success rates, and accelerate FDA approvals through continuous regulatory intelligence.